Neurocrine Biosciences Inc
![Neurocrine Biosciences Inc](https://api.admiralmarkets.com/trade_icons/bright-128/NBIX.png)
Closed
Sector Healthcare
120.13 -0.83
Overview
Share price change
24h
Min
119.75
Max
121.15
Income | 22M 65M |
---|---|
Sales | 65M 580M |
P/E Sector Avg | 37.41 103.001 |
EPS | 1.63 |
Profit margin | 11.207 |
Employees | 1,400 |
EBITDA | 113M 155M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +40.73 upside |
Next Earnings | 29 paź 2024 |
---|
Market Cap | -2.3B 13B |
---|---|
Previous open | 120.96 |
Previous close | 120.13 |
News Sentiment
By Acuity
71%
29%
313 / 365 Ranking in Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Neurocrine Biosciences Inc Chart
Related News
Peer Comparison
Price change
Neurocrine Biosciences Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 169.11 USD 40.73%
High 219 USD
Low 128 USD
Based on 22 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$